Mycamine and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Mycamine (micafungin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Sepsis when taking Mycamine. It is created by eHealthMe based on reports of 2,229 people who have side effects when taking Mycamine from the FDA, and is updated regularly.

What is Mycamine?

Mycamine has active ingredients of micafungin sodium. eHealthMe is studying from 2,237 Mycamine users. Check the latest studies of Mycamine.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,523 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 13, 2026

2,229 people reported to have side effects when taking Mycamine.
Among them, 71 people (3.19%) have Sepsis.

Among these 71 people:

How long have people been on Mycamine when they have Sepsis? *

What is the gender of people who have Sepsis when taking Mycamine? *

female: 31.82 %
male: 68.18 %

What is the age of people who have Sepsis when taking Mycamine? *

What are other drugs people take besides Mycamine? *

What are other side effects people have besides Sepsis? *

Fever: 12 people, 16.90%
Arrhythmias (irregular heartbeat): 9 people, 12.68%
Fungal Infection: 9 people, 12.68%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 8 people, 11.27%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 11.27%
Blood Bilirubin Increased: 7 people, 9.86%
Multi-Organ Failure (multisystem organ failure): 7 people, 9.86%
Alanine Aminotransferase Increased: 7 people, 9.86%
Pneumonia: 7 people, 9.86%
Thrombocytopenia (decrease of platelets in blood): 7 people, 9.86%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 15 people, 21.13%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 9 people, 12.68%
Pain: 6 people, 8.45%
Constipation: 5 people, 7.04%
Systemic Candida (whole body fungal infection): 5 people, 7.04%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 5.63%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 4.23%
Headache (pain in head): 3 people, 4.23%
High Blood Pressure: 3 people, 4.23%
Infection: 3 people, 4.23%

* Approximation only. Some reports may have incomplete information.

Do you take Mycamine and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycamine:

Mycamine (2,237 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Mycamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,523 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

Related publications that referenced our studies

Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .
Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Mycamine) and Mycamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.